CORDIS · 241919 · FP7
LIVIMODE Light-based functional in vivo monitoring of diseases related enzymes
Coordinator: INSTITUT JOZEF STEFAN (SI)
LIVIMODE aims to develop specific tools for non invasive in vivo imaging of disease related molecular events. Such tools are of high relevance for disease detection, staging, developing animal models of human disease, and evaluating novel therapies. We propose to use optical imaging, which is optimally suited for this task as it provides excellent sensitivity and allows visualizing molecular events via a fluorescent signal. While optical imaging technology has rapidly evolved over the last years, the availability of SMART (activatable) imaging agents that change their fluorescence properties …
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €4.9M awarded to the consortium. The project runs over approximately 3.5 years from 2009-11-01 to 2013-04-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from SI
see all →- InnoRenew CoE — Renewable materials and healthy environments research and innovation centre of excellence739574 · H2020 · €15.0M
- Upsurge — City-centered approach to catalyze nature-based solutions through the EU Regenerative Urban Lighthouse for pollution alleviation and regenerative development101003818 · H2020 · €9.3M
- HELIS — High energy lithium sulphur cells and batteries666221 · H2020 · €8.0M
- STREAM — Streaming flexibility to the power system101075654 · HORIZON · €7.9M
- CINDERELA — New Circular Economy Business Model for More Sustainable Urban Construction776751 · H2020 · €6.7M
- MIKELANGELO — MIcro KErneL virtualizAtioN for hiGh pErfOrmance cLOud and hpc systems645402 · H2020 · €6.0M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CP-FP funding scheme.
- What is the EU contribution?
- The European Commission contributes €4.9M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by INSTITUT JOZEF STEFAN (SI).
- What is the project timeline?
- The project runs from 2009-11-01 to 2013-04-30 — approximately 3.5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 241919.